Legislative Services  |  Legislative Audits
Bill number does not exist. Enter a vaild keyword.
Facebook Twitter Youtube Channels
facebook twitter
Facebook Twitter
Click to add bill to MyMGA list

SB0435

Original
Chamber
1st
Reading
Referral
to Cmte
2nd
Reading
3rd
Reading
Opposite
Chamber
1st
Reading
Referral
to Cmte
2nd
Reading
3rd
Reading
Review in
Original Chamber
Passed Both
Chambers
Conf. Cmte
(if necessary)
To Governor
Title
Public Health - Medetomidine and Xylazine Consumer Protection Act
Sponsored by
Senator Folden
Status
In the Senate - First Reading Finance
Analysis
Synopsis
Prohibiting a retailer from distributing, selling, or exposing for sale a medetomidine product or xylazine product unless the purchaser provides proof the intended use is for institutional, veterinary, or scientific purposes; prohibiting a retailer from distributing, selling, or exposing for sale a medetomidine or xylazine product to an individual under the age of 21 years; requiring a retailer that prepares, distributes, sells, or exposes for sale a medetomidine or xylazine product to maintain certain records; etc.
Committees
Original:
Finance
Details
Cross-filed with: HB0417
Introduced in a prior session as: SB0875 Session: 2025 Regular Session
Bill File Type: Regular
Effective Date(s): October 1, 2026
History
Legislation History
Chamber
Senate
Calendar Date
1/30/2026
Legislative Date
1/30/2026
Action
First Reading Finance
Proceedings
Chamber Calendar Date Legislative Date Action Proceedings
Senate 1/30/2026 1/30/2026 First Reading Finance
File Code
Subjects
Statutes
Last Updated: 1/30/2026 12:10 AM
Click to return on the top page